New weight loss drug shows promise in early trial
NCT ID NCT06532578
First seen Apr 17, 2026 · Last updated May 15, 2026 · Updated 5 times
Summary
This study tested a new drug called CPX101 to help overweight and obese people lose weight. 240 adults without diabetes received either the drug or a placebo for 24 weeks. The goal was to see if the drug safely reduces body weight and waist size.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OVERWEIGHT AND OBESITY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Paratus Clinical Research
Chatswood, New South Wales, Australia
Conditions
Explore the condition pages connected to this study.